BrightSpring Health Soars Post-IPO on Strong Earnings and Upbeat Analyst Targets

BrightSpring Health Services, Inc. (NASDAQ:BTSG) is one of the 11 Best Performing IPOs in the Last 2 Years.

The company sees its price target elevated by analysts following a positive second quarter and an upward change in revenue and adjusted EBITDA guidance.

BrightSpring Health Services, Inc. (NASDAQ:BTSG) announced a 29% year-over-year revenue growth, reaching $3.1 billion for Q2 2025. Its earnings call transcript, released on August 1, 2025, further indicated a growth in revenue in its Pharmacy Solutions by 32% year-over-year, with specialty scripts experiencing a 38% increase. Following such strong performance, the company elevated its 2025 revenue and adjusted EBITDA guidance, signaling a positive outlook.

Subsequently, many analysts have raised their price target on the stock. Deutsche Bank, for instance, raised the price target from $25 to $30 while Bank of America increased it from $27.50 to $31. The consensus rating on the stock remains a Buy.

BrightSpring Health Services, Inc. (NASDAQ:BTSG) has shown significant growth since its IPO, with the % growth to date standing notably at 147.09%.

BrightSpring Health Services, Inc. (NASDAQ:BTSG) is a leading healthcare company founded in 1974. Headquartered in Kentucky, the company specializes in providing home and community-based health and pharmacy services to people with complex health needs.

While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Best Freight Stocks to Invest in Now and 12 Jim Cramer Stock Picks this Week

Disclosure. None.